ZANCONATI, FABRIZIO
 Distribuzione geografica
Continente #
EU - Europa 45.065
NA - Nord America 34.102
AS - Asia 16.018
SA - Sud America 2.071
Continente sconosciuto - Info sul continente non disponibili 1.631
AF - Africa 596
OC - Oceania 71
AN - Antartide 1
Totale 99.555
Nazione #
US - Stati Uniti d'America 33.429
IT - Italia 27.909
SG - Singapore 5.692
PL - Polonia 5.415
CN - Cina 3.644
SE - Svezia 2.377
HK - Hong Kong 1.631
UA - Ucraina 1.605
BR - Brasile 1.592
VN - Vietnam 1.556
DE - Germania 1.516
FR - Francia 1.389
KR - Corea 924
GB - Regno Unito 817
FI - Finlandia 793
RU - Federazione Russa 747
BD - Bangladesh 615
NL - Olanda 596
TR - Turchia 493
IN - India 459
IE - Irlanda 398
BG - Bulgaria 380
CA - Canada 348
CH - Svizzera 230
MA - Marocco 228
BE - Belgio 173
JP - Giappone 158
MX - Messico 147
AR - Argentina 145
ES - Italia 130
IQ - Iraq 110
AT - Austria 105
ZA - Sudafrica 105
EC - Ecuador 76
RO - Romania 76
ID - Indonesia 75
PK - Pakistan 68
SA - Arabia Saudita 64
EU - Europa 61
IR - Iran 60
VE - Venezuela 59
AU - Australia 57
CO - Colombia 55
PH - Filippine 53
SN - Senegal 51
CZ - Repubblica Ceca 49
CL - Cile 46
MY - Malesia 45
DZ - Algeria 44
UZ - Uzbekistan 42
AL - Albania 41
PT - Portogallo 40
EG - Egitto 37
AE - Emirati Arabi Uniti 36
KE - Kenya 36
PY - Paraguay 36
IL - Israele 32
TH - Thailandia 32
GR - Grecia 30
LT - Lituania 30
HR - Croazia 28
SI - Slovenia 28
CR - Costa Rica 27
TW - Taiwan 27
JO - Giordania 26
DK - Danimarca 25
TN - Tunisia 25
TT - Trinidad e Tobago 25
UY - Uruguay 24
AZ - Azerbaigian 21
JM - Giamaica 21
RS - Serbia 21
HU - Ungheria 20
NP - Nepal 19
OM - Oman 17
PE - Perù 17
BO - Bolivia 16
EE - Estonia 16
GT - Guatemala 15
KZ - Kazakistan 15
PA - Panama 15
HN - Honduras 14
CI - Costa d'Avorio 13
ET - Etiopia 13
KW - Kuwait 13
GE - Georgia 12
SK - Slovacchia (Repubblica Slovacca) 12
NO - Norvegia 11
NZ - Nuova Zelanda 11
BY - Bielorussia 10
KG - Kirghizistan 10
LB - Libano 10
LU - Lussemburgo 10
NI - Nicaragua 10
SV - El Salvador 10
SY - Repubblica araba siriana 9
BA - Bosnia-Erzegovina 8
DO - Repubblica Dominicana 8
LV - Lettonia 8
PR - Porto Rico 8
Totale 97.835
Città #
Warsaw 4.993
Ashburn 3.594
Singapore 3.501
Woodbridge 2.489
Ann Arbor 2.225
Fairfield 2.146
Chandler 2.108
Houston 1.878
San Jose 1.860
Trieste 1.685
Milan 1.545
Hong Kong 1.528
Jacksonville 1.432
Rome 1.382
Wilmington 1.197
Seoul 896
Seattle 841
Beijing 840
Hefei 801
Council Bluffs 778
Cambridge 727
Princeton 640
Boardman 618
Columbus 550
Duino-Aurisina 536
Santa Clara 520
Chicago 499
Dallas 487
Ho Chi Minh City 474
Los Angeles 446
Naples 398
Dublin 381
Sofia 373
Lauterbourg 340
Hanoi 329
Turin 327
Izmir 326
Zgierz 310
Florence 296
Moscow 295
The Dalles 288
Bologna 282
New York 275
Dearborn 274
Munich 241
Buffalo 236
Frankfurt am Main 232
Helsinki 231
Padova 231
Palermo 197
London 188
São Paulo 186
Casablanca 185
Venezia 174
Düsseldorf 153
Napoli 153
Bari 145
San Diego 143
Brussels 142
Atlanta 139
Genoa 139
Toronto 136
Torino 131
Udine 129
Phoenix 126
Catania 125
Falls Church 120
Brescia 117
Verona 109
Orem 101
Redwood City 100
Tokyo 98
Dong Ket 95
Cagliari 94
Jinan 94
Shanghai 90
Bremen 89
Amsterdam 88
Guangzhou 85
Turku 85
Chennai 83
Venice 83
Perugia 82
Nuremberg 77
Treviso 76
Mestre 70
Nanjing 69
Bergamo 68
Pisa 67
Montreal 64
Da Nang 63
Redmond 63
Vienna 63
North Bergen 62
Des Moines 61
Denver 60
Pescara 59
Johannesburg 56
Monza 56
Mumbai 56
Totale 54.175
Nome #
Valutazione quantitativa di Ki-67 nel carcinoma mammario: comparazione tra lettura al microscopio ottico e lettura con analizzatore automatico 21.871
VALUTAZIONE DEL TOUCH-IMPRINT CITOLOGICO NEL TRATTAMENTO DEL CANCRO DELLA MAMMELLA 1.388
HUMAN PAPILLOMAVIRUS GENOTYPING IN OROPHARYNGEAL SQUAMOUS CELL CARCINOMA WITHOUT DNA EXTRACTION THROUGH EASYPAP DIRECT HPV DNA TEST 651
Il Registro Regionale delle Morti Cardiache Improvvise in età giovanile del Friuli Venezia Giulia. Protocolli operativi e risultati di un progetto multidisciplinare 646
An application of time-driven activity-based costing in a hospital setting 615
Gestione delle pazienti con tumore fillode della mammella: esperienza triestina nel periodo 2006-2014 614
Association between benign thyroid disease and breast cancer: A single center experience 489
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 484
Studio pilota sul ruolo dell’allattamento e dei fattori riproduttivi nel rischio dei carcinomi mammari Luminali nelle donne in premenopausa 474
Potential applications of nanocellulose-containing materials in the biomedical field 474
A simplified edge illumination set-up for quantitative phase contrast mammography with synchrotron radiation at clinical doses 465
Analisi dei tempi d’attesa tra le varie fasi di gestione dei carcinomi mammari screening-detected a Trieste nel biennio 2013-2014: come si può migliorare? 462
Cyclin dependent kinase 4 and 6 inhibitors as novel therapeutic agents for targeted treatment of malignant mesothelioma 461
Cutaneous melanoma frequencies and seasonal trend in 20 years of observation of a population characterised by excessive sun exposure 460
Surgical and pathological changes after radiofrequency ablation of thyroid nodules 447
A vivens ex vivo study on the synergistic effect of electrolysis and freezing on the cell nucleus 444
NEODUCTGENESIS AS A PROGNOSTIC MARKER IN “DUCTAL” CARCINOMA IN SITU OF THE BREAST 433
Fibrosi retroperitoneale e mesenterica. Una "sindrome da carcinoide" di non frequente riscontro 431
Advances in systemic therapy for metastatic breast cancer: future perspectives 430
Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment 423
Complement Protein C1q binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumour Growth 410
Breastfeeding: a reproductive factor able to reduce the risk of luminal B breast cancer in premenopausal White women 407
Her2 immunohistochemical evaluation by traditional microscopy and by digital analysis, and the consequences for FISH testing 406
Cell-free DNA integrity for the monitoring of breast cancer: Future perspectives? 404
GT75 aptamer against eukaryotic elongation factor 1A as potential anticancer drug for castrate-resistant prostate cancer (CRPC). 400
Usefulness of core needle biopsy for the diagnosis of thyroid Burkitt's lymphoma: a case report and review of the literature 378
An analysis of advanced cost accounting techniques in healthcare activities 376
Need for randomized clinical trials testing targeted therapies in malignant pleural mesothelioma 373
Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat 366
Breast cytology: reporting 353
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility 345
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer 343
12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules 342
Strategies for delivery of siRNAs to ovarian cancer cells 342
Therapeutic potential of Nucleic acid-based drugs in coronary hyper-proliferative vascular diseases 335
Multicenter research into the quality of life of patients with advanced oropharyngeal carcinoma with long-term survival associated with human papilloma virus 335
Parità e Allattamento quali fattori protettivi di carcinoma mammario nelle donne triestine 333
Breastfeeding is an additional protective factor for breast cancer among women living in the metropolitan area of Trieste. 332
Advancements towards the implementation of clinical phase-contrast breast computed tomography at Elettra 332
RELIABILITY OF P16 IMMUNOHISTOCHEMISTRY IN THE DISCRIMINATION OF HPV-POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA 330
BIOINFORMATICS ANALYSIS OF THE CLINICOPATHOLOGICAL SIGNIFICANCE AND THE PROGNOSTIC ROLE OF SURFACTANT PROTEIN D IN LUNG, GASTRIC, BREAST AND OVARIAN CANCERS 329
Breast FNAC in Mammografic Screening Program of Trieste,Italy 327
Patient satisfaction after thyroid RFA versus surgery for benign thyroid nodules: a telephone survey 320
Cyto-radiological disageement: management 318
Pathological significance and prognostic value of surfactant protein D in cancer 316
Interval Breast Cancer Versus Screen-Detected Cancer: Comparison of Clinicopathologic Characteristics in a Single-Center Analysis 316
Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma 314
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion 309
X-ray phase-contrast tomography of breast tissue specimen with a multi-aperture analyser synchrotron set-up 306
Quantitative characterization of breast tissues with dedicated CT imaging 305
The risk of developing a CIN2+ lesion in women with HPV16 and 18, versus women with other HPV types: follow up study 305
null 302
Monochromatic breast computed tomography with synchrotron radiation: phase-contrast and phase-retrieved image comparison and full-volume reconstruction 301
Effects of formalin, methacarn, and fineFIX fixatives on RNA preservation. 300
BREAST CYTOLOGY: AN EXAMPLE OF STRONG SYNERGY BETWEEN MORFOLOGY AND CLINICAL NEEDS 299
Novel Lipid and Polymeric Materials as Delivery Systems for Nucleic Acid Based Drugs 298
null 297
Tumour infiltrating lymphocytes and PD-L1 expression as potential predictors of outcome in patients with malignant pleural mesothelioma 294
Monochromatic breast CT: absorption and phase-retrieved images 292
Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis 291
Effect of class IV laser therapy on chemotherapy-induced oral mucositis: a clinical and experimental study. 290
Dissecting the role of the elongation factor 1A isoforms in hepatocellular carcinoma cells by liposome-mediated delivery of siRNAs 287
Deciduosi linfonodale ed ovarica versus metastasi di adenocarcinoma endocervicale in donna in gravidanza 285
Role of the complement protein C1q in the regulation of hyaluronic acid cleavage in malignant pleural mesothelioma 284
Breast tomography with synchrotron radiation 283
Advances in systemic therapy for malignant mesothelioma: Future perspectives 283
Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancers 283
Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study. 280
Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics analysis involving human carcinomas 279
Towards breast tomography with synchrotron radiation at Elettra: first images 279
Aptamer targeting of the elongation factor 1A impairs hepatocarcinoma cells viability and potentiates bortezomib and idarubicin effects 278
Radiofrequency ablation for benign thyroid nodules 277
Clinical mammography at the SYRMEP beam line 276
Fibromatosi mesenterica: descrizione di un caso ad esordio occlusivo intestinale 275
Optimization of propagation-based x-ray phase-contrast tomography for breast cancer imaging 275
Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma. 273
NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress 272
Toward Improving Breast Cancer Imaging: Radiological Assessment of Propagation-Based Phase-Contrast CT Technology 270
Breast Cytopathology. Assessing the Value of FNAC in the Diagnosis of Breast Lesions 268
Prognostic-predictive factors in breast cancer: comparison of mRNA level (Target Print) and immunohistochemistry expression 265
The PICASSO digital detector for Diffraction Enhanced Imaging at ELETTRA 265
Analisi delle caratteristiche dei carcinomi d’intervallo e screening detected a 10 anni dall’attivazione del programma di screening mammografico regionale del Friuli Venezia-Giulia nella provincia di Trieste 264
A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects 261
MALIGNANT PLEURAL MESOTHELIOMA WITH “SIGNETRING” CELLS: A DIAGNOSTIC CHALLENGE AND AN UNUSUAL CASE REPORT 261
PROGNOSTIC ROLE OF TUMOR INFILTRATING LYMPHOCITES (TILS) IN EPITHELIOID PLEURAL MESOTHELIOMA 258
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 258
ADVANCED ADENOMA IN SCREENING POPULATION AND LIFE STYLE HABITS: A CASE CONTROL STUDY 257
Breast citology 257
Phase-contrast clinical breast CT: Optimization of imaging setups and reconstruction workflows 257
Charcoal suspension tattoo: new tool for the localization of malignant laterocervical lymph nodes 255
A rapid and specific method to simultaneously quantify eukaryoticelongation factor 1A1 and A2 protein levels in cancer cells 253
Translation Elongation 252
Biology, prognosis and response to therapy of breast carcinomas according to HER2 score 250
A case of burkitt-like B lymphoblastic lymphoma 250
The prognostic value of PI3K mutational status in breast cancer: A meta-analysis 249
Metastatic angioimmunoblastic T-cell lymphoma started from thoracic paravertebral region: a Case report 247
Caratteristiche dei carcinomi screening-detected a 6 anni dall’ avvio del programma di screening mammografico a Trieste 245
SYRMEP: SR digital imaging of breast tissue samples 244
Dissecting the expression of EEF1A1/A2 genes in human prostate cancer cells: the potential od EEF1A2 as a hallmark for prostate transformation and progression 243
Measurement of the linear attenuation coefficients of breast tissues by synchrotron radiation computed tomography 243
Totale 56.174
Categoria #
all - tutte 234.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.001


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.095 0 0 440 613 253 411 312 320 652 565 384 1.145
2022/202310.228 789 1.043 835 1.165 839 1.352 401 973 1.069 409 698 655
2023/20247.915 673 622 608 530 640 603 942 1.029 176 983 594 515
2024/202511.159 454 732 1.262 888 976 984 756 589 1.335 1.225 894 1.064
2025/202621.587 2.092 1.138 1.447 2.050 1.764 1.938 2.946 705 2.320 3.057 1.181 949
2026/20272.991 764 1.186 1.041 0 0 0 0 0 0 0 0 0
Totale 99.555